NLS Pharmaceutics Ltd (NLSP)
0.1533
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.153
0.00 (0.00%)
After-Hours: 17:16
NLS Pharmaceutics Market Cap: 6.641M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 6.472M |
| May 15, 2024 | 6.325M |
| May 14, 2024 | 6.537M |
| May 13, 2024 | 6.086M |
| May 10, 2024 | 6.034M |
| May 09, 2024 | 6.130M |
| May 08, 2024 | 6.004M |
| May 07, 2024 | 6.060M |
| May 06, 2024 | 5.892M |
| May 03, 2024 | 5.978M |
| May 02, 2024 | 5.892M |
| May 01, 2024 | 5.801M |
| April 30, 2024 | 6.052M |
| April 29, 2024 | 6.136M |
| April 26, 2024 | 5.922M |
| April 25, 2024 | 5.736M |
| April 24, 2024 | 5.415M |
| April 23, 2024 | 5.640M |
| April 22, 2024 | 5.627M |
| April 19, 2024 | 5.749M |
| April 18, 2024 | 5.749M |
| April 17, 2024 | 5.762M |
| April 16, 2024 | 5.935M |
| April 15, 2024 | 6.130M |
| April 12, 2024 | 6.481M |
| Date | Value |
|---|---|
| April 11, 2024 | 6.652M |
| April 10, 2024 | 6.481M |
| April 09, 2024 | 6.468M |
| April 08, 2024 | 6.091M |
| April 05, 2024 | 6.160M |
| April 04, 2024 | 6.68M |
| April 03, 2024 | 6.931M |
| April 02, 2024 | 7.620M |
| April 01, 2024 | 7.468M |
| March 28, 2024 | 7.798M |
| March 27, 2024 | 7.152M |
| March 26, 2024 | 7.572M |
| March 25, 2024 | 7.170M |
| March 22, 2024 | 7.798M |
| March 21, 2024 | 6.171M |
| March 20, 2024 | 5.702M |
| March 19, 2024 | 9.785M |
| March 18, 2024 | 9.799M |
| March 15, 2024 | 11.22M |
| March 14, 2024 | 12.16M |
| March 13, 2024 | 12.40M |
| March 12, 2024 | 10.70M |
| March 11, 2024 | 11.98M |
| March 08, 2024 | 10.99M |
| March 07, 2024 | 11.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.415M
Minimum
Apr 24 2024
68.98M
Maximum
Mar 12 2021
26.28M
Average
25.29M
Median
Oct 10 2023
Market Cap Benchmarks
| AC Immune SA | 317.47M |
| CRISPR Therapeutics AG | 4.772B |
| Addex Therapeutics Ltd | 9.384M |
| Molecular Partners AG | 127.15M |
| MoonLake Immunotherapeutics | 2.499B |
Market Cap Related Metrics
| Price | 0.1533 |